Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

Journal of Gastroenterology

Volumn 42, Issue 5, 2007, Pages 375-381

  Yoneda, Masato ^a   Mawatari, Hironori ^a   Fujita, Koji ^a   Yonemitsu, Kyoko ^a   Kato, Shingo ^a   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Inamori, Masahiko ^a   Nozaki, Yuichi ^a   Abe, Yasunobu ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Iwasaki, Tomoyuki ^b   Terauchi, Yasuo ^b   Togo, Shinji ^b   Maeyama, Shiro ^c   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kitakashiwa Rehabilitation Hospital   (Japan)

Author keywords

Biomarker; Liver fibrosis; NASH; Type IV collagen 7s domain

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; COLLAGEN TYPE 4; HYALURONIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; BLOOD; FATTY LIVER; FIBROSIS; INSULIN RESISTANCE; LIVER; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; ROC CURVE; STATISTICAL MODEL;

ADULT; COLLAGEN TYPE IV; DISEASE PROGRESSION; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; HYALURONIC ACID; INSULIN RESISTANCE; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE;

EID: 34447519882     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2014-3     Document Type: Article

References (32)

1. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 18 1221-31 10.1056/NEJMra011775
2. GC Farrell 2003 Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18 124-38 12542595 10.1046/j.1440-1746.2003.02989.x
3. AM Diehl Z Goodman KG Ishak 1988 Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 95 1056-62 3410220 1:STN:280:BieA3MzltVc%3D
4. J Ludwig TR Viggiano DB McGill BJ Oh 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 434-8 7382552 1:STN:280:Bi%2BB3cfjvFM%3D
5. EM Brunt 2001 Nonalcoholic steatohepatitis: Definition and pathology Semin Liver Dis 21 3-16 11296695 10.1055/s-2001-12925 1:STN:280:DC%2BD3MrgsVGrtg%3D%3D
6. JF Cadranel 2002 Good clinical practice guidelines for fine needle aspiration biopsy of the liver: Past, present and future Gastroenterol Clin Biol 26 823-4 12434092 1:STN:280:DC%2BD38nntlaruw%3D%3D
7. T Poynard V Ratziu P Bedossa 2000 Appropriateness of liver biopsy Can J Gastroenterol 14 543-8 10888734 1:STN:280:DC%2BD3czptlahsQ%3D%3D
8. P Angulo JC Keach KP Batts KD Lindor 1999 Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1356-62 10573511 10.1002/hep.510300604 1:STN:280:DC%2BD3c%2Fkt1ejtQ%3D%3D
9. V Ratziu P Giral F Charlotte E Bruckert V Thibault I Theodorou 2000 Liver fibrosis in overweight patients Gastroenterology 118 1117-23 10833486 10.1016/S0016-5085(00)70364-7 1:STN:280:DC%2BD3c3psFSntg%3D%3D
10. M Shimada E Hashimoto H Kaneda S Noguchi N Hayashi 2002 Nonalcoholic steatohepatitis: Risk factors for liver fibrosis Hepatol Res 24 429-38 12479942 10.1016/S1386-6346(02)00246-2
11. U Lindqvist TC Laurent 1992 Serum hyaluronan and aminoterminal propeptide of type III procollagen: Variation with age Scand J Clin Lab Invest 52 613-21 1455153 1:STN:280:ByyD1cjpslc%3D
12. T Ueno S Inuzuka T Torimura H Oohira H Ko K Obata 1992 Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen Scand J Gastroenterol 27 513-20 1631498 1:STN:280:By2A3srotVY%3D
13. Y Murawaki Y Ikuta M Koda H Kawasaki 1994 Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology Hepatology 20 780-7 7927217 10.1002/hep.1840200403 1:STN:280:ByqD3M3gvFU%3D
14. T Suou S Yamada K Hosho N Yoshikawa H Kawasaki 1996 Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease Hepatology 23 1154-8 8621148 10.1002/hep.510230533 1:STN:280:BymB3cnlsVM%3D
15. H Sakugawa T Nakayoshi K Kobashigawa T Yamashiro T Maeshiro S Miyagi 2005 Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease World J Gastroenterol 11 255-9 15633226 1:CAS:528:DC%2BD2MXhs1eiur0%3D
16. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-9 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D
17. JC Levy DR Matthews MP Hermans 1998 Correct homeostasis model assessment (HOMA) evaluation uses the computer program Diabetes Care 21 2191-2 9839117 10.2337/diacare.21.12.2191 1:STN:280:DyaK1M%2Fls1CqtA%3D%3D
18. T Ono N Shiga Y Taneda S Umemura 1999 The fasting-plasma glucose range in which insulin resistance measured by homeostasis model assessment correlates with euglycemic clamping J Jpn Diabetes Soc 42 1005-11
19. T Yoshizumi T Nakamura M Yamane AH Islam M Menju K Yamasaki 1999 Abdominal fat: Standardized technique for measurement at CT Radiology 211 283-6 10189485 1:STN:280:DyaK1M3gsFCrsQ%3D%3D
20. MR Teli OF James AD Burt MK Bennett CP Day 1995 The natural history of nonalcoholic fatty liver: A follow-up study Hepatology 22 1714-9 7489979 1:STN:280:BymD1cfot1M%3D
21. CA Matteoni ZM Younossi T Gramlich N Boparai YC Liu AJ McCullough 1999 Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity Gastroenterology 116 1413-9 10348825 10.1016/ S0016-5085(99)70506-8 1:STN:280:DyaK1M3nvVamtw%3D%3D
22. JM Hui JG Kench S Chitturi A Sud GC Farrell K Byth 2003 Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C Hepatology 38 420-7 12883486 10.1053/jhep.2003.50320
23. AJ Sanyal 2002 Treatment of non-alcoholic fatty liver disease J Gastroenterol Hepatol 17 Suppl 3 S385-8 12472968 10.1046/ j.1440-1746.17.s3.32.x
24. J Choudhury AJ Sanyal 2004 Clinical aspects of fatty liver disease Semin Liver Dis 24 349-62 15605303 10.1055/s-2004-860864
25. AJ Sanyal 2002 AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 1705-25 12404245 10.1053/gast.2002.36572
26. AE Reid 2001 Nonalcoholic steatohepatitis Gastroenterology 121 710-23 11522755 10.1053/gast.2001.27126 1:STN:280:DC%2BD3MvnvFSltg%3D%3D
27. S Saadeh ZM Younossi EM Remer T Gramlich JP Ong M Hurley 2002 The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 745-50 12198701 10.1053/gast.2002.35354
28. J Guechot RE Poupon P Giral B Balkau J Giboudeau R Poupon 1994 Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C J Hepatol 20 388-93 8014451 10.1016/S0168-8278(94)80013-8 1:CAS:528:DyaK2cXktVKntLY%3D
29. S Takamatsu H Nakabayashi Y Okamoto H Nakano 1997 Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables J Gastroenterol 32 355-60 9213250 1:STN:280:ByiA2MnotFA%3D
30. CT Wai JK Greenson RJ Fontana JD Kalbfleisch JA Marrero HS Conjeevaram 2003 A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 518-26 12883497 10.1053/jhep.2003.50346
31. PR Gibson JR Fraser TJ Brown CF Finch PA Jones JC Colman 1992 Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease Hepatology 15 1054-9 1592343 10.1002/ hep.1840150614 1:STN:280:By2B2srltlw%3D
32. RE Poupon B Balkau J Guechot F Heintzmann 1994 Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue Hepatology 19 635-40 8119688 10.1002/hep.1840190314 1:STN:280:ByuC28vmsVE%3D